-
1
-
-
84885457470
-
Total spondylectomy following carbon ion radiotherapy to treat chordoma of the mobile spine
-
T. Matsumoto S. Imagama Z. Ito R. Imai T. Kamada Y. Shimoyama Y. Matsuyama and N. Ishiguro, Total spondylectomy following carbon ion radiotherapy to treat chordoma of the mobile spine, Bone Joint J 95-B(10) (2013), 1392-1395
-
(2013)
Bone Joint J
, vol.95 B
, Issue.10
, pp. 1392-1395
-
-
Matsumoto, T.1
Imagama, S.2
Ito, Z.3
Imai, R.4
Kamada, T.5
Shimoyama, Y.6
Matsuyama, Y.7
Ishiguro, N.8
-
2
-
-
0035141448
-
Chordoma: Incidence and survival patterns in the United States, 1973-1995
-
M.S. MacMaster A.M. Goldstein C.M. Bromley N. Ishibe and D.M. Parry, Chordoma: incidence and survival patterns in the United States, 1973-1995, Cancer Causes Control 12(1) (2001), 1-11
-
(2001)
Cancer Causes Control
, vol.12
, Issue.1
, pp. 1-11
-
-
MacMaster, M.S.1
Goldstein, A.M.2
Bromley, C.M.3
Ishibe, N.4
Parry, D.M.5
-
3
-
-
0034194216
-
Prognostic factors in chordoma of the sacrum and mobile spine. A study of 39 patients
-
P. Bergh L.G. Kingblom B. Gunterberg F. Remotti W. Ryd and J.M. Meis-Kindblom, Prognostic factors in chordoma of the sacrum and mobile spine. A study of 39 patients, Cancer 88(9) (2000), 2122-2134
-
(2000)
Cancer
, vol.88
, Issue.9
, pp. 2122-2134
-
-
Bergh, P.1
Kingblom, L.G.2
Gunterberg, B.3
Remotti, F.4
Ryd, W.5
Meis-Kindblom, J.M.6
-
4
-
-
79955560946
-
Long-term results: Adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable
-
W.A. Moojen C.L. Vleggeert-Lankamp A.D. Krol and S.P. Dijkstra, Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable, Spine (Phila Pa 1976) 36(10) (2011), E656-61
-
(2011)
Spine (Phila Pa 1976
, vol.36
, Issue.10
, pp. E656-E661
-
-
Moojen, W.A.1
Vleggeert-Lankamp, C.L.2
Krol, A.D.3
Dijkstra, S.P.4
-
5
-
-
33750697944
-
Metastatic disease from spinal chordoma: A 10-year experience
-
C.M. McPherson D. Suki I.E. McCutcheon Z.L. Gokaslan L.D. Rhines and E. Mendel, Metastatic disease from spinal chordoma: a 10-year experience, J Neurosurg Spine 5(4) (2006), 277-280
-
(2006)
J Neurosurg Spine
, vol.5
, Issue.4
, pp. 277-280
-
-
McPherson, C.M.1
Suki, D.2
McCutcheon, I.E.3
Gokaslan, Z.L.4
Rhines, L.D.5
Mendel, E.6
-
6
-
-
77957703704
-
Surgical margins and local control in resection of sacral chordomas
-
P. Ruggieri A. Angelini G. Ussia M. Montalti and M. Mercuri, Surgical margins and local control in resection of sacral chordomas, Clin Orthop Relat Res 468(11) (2010), 2939-2947
-
(2010)
Clin Orthop Relat Res
, vol.468
, Issue.11
, pp. 2939-2947
-
-
Ruggieri, P.1
Angelini, A.2
Ussia, G.3
Montalti, M.4
Mercuri, M.5
-
7
-
-
71949129297
-
Chordoma of the sacrum and vertebral bodies
-
D.M. Sciubba J.J. Cheng R.J. Petteys K.L. Weber D.A. Frassica and Z.L. Gokaslan, Chordoma of the sacrum and vertebral bodies, J Am Acad Orthop Surg 17(11) (2009), 708-717
-
(2009)
J Am Acad Orthop Surg
, vol.17
, Issue.11
, pp. 708-717
-
-
Sciubba, D.M.1
Cheng, J.J.2
Petteys, R.J.3
Weber, K.L.4
Frassica, D.A.5
Gokaslan, Z.L.6
-
8
-
-
50649086606
-
Sacral chordoma: Can local recurrence after sacrectomy be predicted?
-
S.A. Hanna W.J. Aston T.W. Briggs S.R. Cannon and A. Saifuddin, Sacral chordoma: can local recurrence after sacrectomy be predicted? Clin Orthop Relat Res 466(9) (2008), 2217-2223
-
(2008)
Clin Orthop Relat Res
, vol.466
, Issue.9
, pp. 2217-2223
-
-
Hanna, S.A.1
Aston, W.J.2
Briggs, T.W.3
Cannon, S.R.4
Saifuddin, A.5
-
9
-
-
35748970514
-
PARP inhibitor development for systemic cancer targeting
-
T. Zaremba and N.J. Curtin, PARP inhibitor development for systemic cancer targeting, Anticancer Agents Med Chem 7(5) (2007), 515-523
-
(2007)
Anticancer Agents Med Chem
, vol.7
, Issue.5
, pp. 515-523
-
-
Zaremba, T.1
Curtin, N.J.2
-
10
-
-
77950023283
-
PARP inhibition: PARP1 and beyond
-
M. Rouleau A. Patel M.J. Hendzel S.H. Kaufmann and G.G. Poirier, PARP inhibition: PARP1 and beyond, Nat Rev Cancer 10(4) (2010), 293-301
-
(2010)
Nat Rev Cancer
, vol.10
, Issue.4
, pp. 293-301
-
-
Rouleau, M.1
Patel, A.2
Hendzel, M.J.3
Kaufmann, S.H.4
Poirier, G.G.5
-
11
-
-
84965068171
-
Role of PARP-1 in prostate cancer
-
D. Deshmukh and Y. Qiu, Role of PARP-1 in prostate cancer, Am J Clin Exp Urol 3(1) (2015), 1-12
-
(2015)
Am J Clin Exp Urol
, vol.3
, Issue.1
, pp. 1-12
-
-
Deshmukh, D.1
Qiu, Y.2
-
12
-
-
84886305149
-
Histone deacetylase inhibitors as potential therapeutic approaches for chordoma: An immunohistochemical and functional analysis
-
S. Scheipl B. Lohberger B. Rinner E.V. Froehlich A. Beham F. Quehenberger A. Lazáry P. Pal Varga J. Haybaeck A. Leithner and B. Liegl, Histone deacetylase inhibitors as potential therapeutic approaches for chordoma: an immunohistochemical and functional analysis, J Orthop Res 31(12) (2013), 1999-2005
-
(2013)
J Orthop Res
, vol.31
, Issue.12
, pp. 1999-2005
-
-
Scheipl, S.1
Lohberger, B.2
Rinner, B.3
Froehlich, E.V.4
Beham, A.5
Quehenberger, F.6
Lazáry, A.7
Pal Varga, P.8
Haybaeck, J.9
Leithner, A.10
Liegl, B.11
-
13
-
-
71649113960
-
Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization
-
H. Yang L. Zhu N.A. Ebraheim X. Liu S. Castillo T. Tang J. Liu and H. Cui, Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization, Spine J 9(12) (2009), 972-980
-
(2009)
Spine J
, vol.9
, Issue.12
, pp. 972-980
-
-
Yang, H.1
Zhu, L.2
Ebraheim, N.A.3
Liu, X.4
Castillo, S.5
Tang, T.6
Liu, J.7
Cui, H.8
-
14
-
-
84893719077
-
Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis
-
K. Chen J. Mo M. Zhou G. Wang G. Wu H. Chen K. Zhang and H. Yang, Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis, Med Oncol 31(4) (2014), 886
-
(2014)
Med Oncol
, vol.31
, Issue.4
, pp. 886
-
-
Chen, K.1
Mo, J.2
Zhou, M.3
Wang, G.4
Wu, G.5
Chen, H.6
Zhang, K.7
Yang, H.8
-
15
-
-
76649119776
-
Prognostic factors of sacral chordoma after surgical therapy: A study of 36 patients
-
K.W. Chen H.L. Yang J. Lu J.Y. Liu and X.Q. Chen, Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients, Spinal Cord 48(2) (2010), 166-171
-
(2010)
Spinal Cord
, vol.48
, Issue.2
, pp. 166-171
-
-
Chen, K.W.1
Yang, H.L.2
Lu, J.3
Liu, J.Y.4
Chen, X.Q.5
-
16
-
-
79952190309
-
Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma
-
K.W. Chen H.L. Yang J. Lu G.L. Wang Y.M. Ji G.Z. Wu L.F. Zhu J.Y. Liu X.Q. Chen and Y.P. Gu, Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma, J Neurooncol 101(3) (2011), 357-363
-
(2011)
J Neurooncol
, vol.101
, Issue.3
, pp. 357-363
-
-
Chen, K.W.1
Yang, H.L.2
Lu, J.3
Wang, G.L.4
Ji, Y.M.5
Wu, G.Z.6
Zhu, L.F.7
Liu, J.Y.8
Chen, X.Q.9
Gu, Y.P.10
-
17
-
-
84855690102
-
Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line mug-chor1
-
B. Rinner E.V. Froehlich K. Buerger H. Knausz B. Lohberger S. Scheipl C. Fischer A. Leithner C. Guelly S. Trajanoski K. Szuhai and B. Liegl, Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1, Int J Oncol 40(2) (2012), 443-451
-
(2012)
Int J Oncol
, vol.40
, Issue.2
, pp. 443-451
-
-
Rinner, B.1
Froehlich, E.V.2
Buerger, K.3
Knausz, H.4
Lohberger, B.5
Scheipl, S.6
Fischer, C.7
Leithner, A.8
Guelly, C.9
Trajanoski, S.10
Szuhai, K.11
Liegl, B.12
-
18
-
-
84922804264
-
A small-molecule protein-protein interaction inhibitor of PARP1 that targets its BRCT domain
-
Z. Na B. Peng S. Ng S. Pan J.S. Lee H.M. Shen and S.Q. Yao, A small-molecule protein-protein interaction inhibitor of PARP1 that targets its BRCT domain, Angew Chem Int Ed Engl 54(8) (2015), 2515-2519
-
(2015)
Angew Chem Int Ed Engl
, vol.54
, Issue.8
, pp. 2515-2519
-
-
Na, Z.1
Peng, B.2
Ng, S.3
Pan, S.4
Lee, J.S.5
Shen, H.M.6
Yao, S.Q.7
-
19
-
-
84926665024
-
SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner
-
Z. Xu L. Zhang W. Zhang D. Meng H. Zhang Y. Jian X. Xu M. Van Meter A. Seluanov V. Gorbunova and Z. Mao, SIRT6 rescues the age related decline in base excision repair in a PARP1-dependent manner, Cell Cycle 14(2) (2015), 269-276
-
(2015)
Cell Cycle
, vol.14
, Issue.2
, pp. 269-276
-
-
Xu, Z.1
Zhang, L.2
Zhang, W.3
Meng, D.4
Zhang, H.5
Jian, Y.6
Xu, X.7
Van Meter, M.8
Seluanov, A.9
Gorbunova, V.10
Mao, Z.11
-
20
-
-
84855544340
-
Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma
-
M. Bao Z. Chen Y. Xu Y. Zhao R. Zha S. Huang L. Liu T. Chen J. Li H. Tu and X. He, Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma, Liver Int 32(2) (2012), 331-338
-
(2012)
Liver Int
, vol.32
, Issue.2
, pp. 331-338
-
-
Bao, M.1
Chen, Z.2
Xu, Y.3
Zhao, Y.4
Zha, R.5
Huang, S.6
Liu, L.7
Chen, T.8
Li, J.9
Tu, H.10
He, X.11
-
21
-
-
84931559839
-
RecQ helicases and PARP1 team up in maintaining genome integrity
-
Pt A
-
S. Veith and A. Mangerich, RecQ helicases and PARP1 team up in maintaining genome integrity, Ageing Res Rev 23(Pt A) (2015), 12-28
-
(2015)
Ageing Res Rev
, vol.23
, pp. 12-28
-
-
Veith, S.1
Mangerich, A.2
-
22
-
-
0034792246
-
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1
-
S. Scheil S. Bruderlein T. Liehr H. Starke J. Herms M. Schulte and P. Möller, Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1, Genes Chromosomes Cancer 32(3) (2001), 203-211
-
(2001)
Genes Chromosomes Cancer
, vol.32
, Issue.3
, pp. 203-211
-
-
Scheil, S.1
Bruderlein, S.2
Liehr, T.3
Starke, H.4
Herms, J.5
Schulte, M.6
Möller, P.7
-
23
-
-
84897101393
-
Expression of PDGFR-alpha, EGFR and c-MET in spinal chordoma: A series of 52 patients
-
R. Akhavan-Sigari M.R. Gaab V. Rohde M. Abili and H. Ostertag, Expression of PDGFR-alpha, EGFR and c-MET in spinal chordoma: a series of 52 patients, Anticancer Res 34(2) (2014), 623-630
-
(2014)
Anticancer Res
, vol.34
, Issue.2
, pp. 623-630
-
-
Akhavan-Sigari, R.1
Gaab, M.R.2
Rohde, V.3
Abili, M.4
Ostertag, H.5
-
24
-
-
84925503952
-
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
-
M. Sajish and P. Schimmel, A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol, Nature 519(7543) (2015), 370-373
-
(2015)
Nature
, vol.519
, Issue.7543
, pp. 370-373
-
-
Sajish, M.1
Schimmel, P.2
-
25
-
-
84925541094
-
Biological and clinical significance of PARP1 protein expression in breast cancer
-
A.R. Green D. Caracappa A.A. Benhasouna A. Alshareeda C.C. Nolan R.D. Macmillan S. Madhusudan I.O. Ellis and E.A. Rakha, Biological and clinical significance of PARP1 protein expression in breast cancer, Breast Cancer Res Treat 149(2) (2015), 353-362
-
(2015)
Breast Cancer Res Treat
, vol.149
, Issue.2
, pp. 353-362
-
-
Green, A.R.1
Caracappa, D.2
Benhasouna, A.A.3
Alshareeda, A.4
Nolan, C.C.5
Macmillan, R.D.6
Madhusudan, S.7
Ellis, I.O.8
Rakha, E.A.9
-
26
-
-
84911807034
-
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation
-
F. Sabbatino C. Fusciello D. Somma R. Pacelli, R. Poudel, D. Pepin, A. Leonardi, C. Carlomagno, G. Della Vittoria Scarpati, S. Ferrone and S. Pepe, Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation, Cytometry A 85(11) (2014), 953-961
-
(2014)
Cytometry A
, vol.85
, Issue.11
, pp. 953-961
-
-
Sabbatino, F.1
Fusciello, C.2
Somma, D.3
Pacelli, R.4
Poudel, R.5
Pepin, D.6
Leonardi, A.7
Carlomagno, C.8
Della Vittoria Scarpati, G.9
Ferrone, S.10
Pepe, S.11
-
27
-
-
84919481004
-
PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1
-
T. Dziaman, H. Ludwiczak, J.M. Ciesla, Z. Banaszkiewicz, A. Winczura, M. Chmielarczyk, E. Wisniewska, A. Marszalek, B. Tudek and R. Olinski, PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1, PLoS One 9(12) (2014), e115558
-
(2014)
Plos One
, vol.9
, Issue.12
, pp. e115558
-
-
Dziaman, T.1
Ludwiczak, H.2
Ciesla, J.M.3
Banaszkiewicz, Z.4
Winczura, A.5
Chmielarczyk, M.6
Wisniewska, E.7
Marszalek, A.8
Tudek, B.9
Olinski, R.10
|